- Training
- June 2023
- 2 Days
Global
From €1453EUR$1,597USD£1,234GBP
- Training
- September 2023
- 2 Days
Global
From €2913EUR$3,200USD£2,474GBP
- Training
- August 2023
- 2 Days
Global
From €2639EUR$2,900USD£2,242GBP
- Training
- March 2024
- 2 Days
Global
From €2913EUR$3,200USD£2,474GBP
- Webinar
- November 2023
- 3 Hours
Global
From €1274EUR$1,400USD£1,082GBP
- Training
- November 2023
- 2 Days
Global
€3356EUR$3,688USD£2,851GBP
- Webinar
- September 2023
- 4 Hours
Global
From €1274EUR$1,400USD£1,082GBP
- Training
- September 2023
- 2 Days
Global
From €1338EUR$1,470USD£1,136GBP
- Webinar
- July 2023
- 4 Hours
Global
From €669EUR$736USD£569GBP
- Training
- May 2023
- 2 Days
Global
From €1341EUR$1,474USD£1,139GBP
- Webinar
- November 2022
- 360 Minutes
Global
From €542EUR$595USD£460GBP
- Training
- March 2021
- 2 Days
Global
From €1728EUR$1,899USD£1,468GBP
- Webinar
- May 2019
- 90 Minutes
Global
- Training
- 12 Hours
Global
€4096EUR$4,500USD£3,479GBP
- Training
- 60 Minutes
Global
- Training
- 120 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 90 Minutes
Global

Out of Specification Results (OOS) is a term used in the pharmaceutical manufacturing industry to describe results that do not meet the predetermined standards of quality. OOS results can be caused by a variety of factors, including incorrect raw materials, incorrect process parameters, or incorrect testing methods. OOS results can have a significant impact on the quality of the final product, and can lead to costly delays in production.
The OOS Results market is comprised of companies that provide services to help pharmaceutical manufacturers identify and address OOS results. These services include consulting, training, and software solutions to help manufacturers identify and address OOS results. Companies in this market include Parexel, IQVIA, and Charles River Laboratories. Show Less Read more